Saturday - December 21, 2024
Litigation: SEC Charges Ex-BioPharma Executive With Insider Trading
December 20, 2024
WASHINGTON, Dec. 20 -- The Securities and Exchange Commission issued the following litigation release (No. 3:24-cv-631-TKW-HTC; N.D. Fla. filed Dec. 18, 2024) involving Curt L Dewitz:

* * *

The Securities and Exchange Commission today announced the filing of a settled insider trading case against Curt L. Dewitz of Inlet Beach, Florida. Dewitz is a former executive of a biopharmaceutical company. The Commission's action alleges that he traded in the securities of two rel . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products